Basic Information
ID: ALA4737529
Type: Functional
Description: Agonist activity at RXFP1 endogenously expressed in human OVCAR-5 cells assessed as increase in IBMX-induced cAMP accumulation pretreated with IBMX for 40 mins followed by compound addition and measured after 30 mins in presence of 2 % HSA by HTRF assay relative to control
Format: BAO_0000219
Organism: Homo sapiens
Cell type: OVCAR-5
Target: Relaxin receptor 1(ALA1293316)
Document: ALA4732190
Agonist activity at RXFP1 endogenously expressed in human OVCAR-5 cells assessed as increase in IBMX-induced cAMP accumulation pretreated with IBMX for 40 mins followed by compound addition and measured after 30 mins in presence of 2 % HSA by HTRF assay relative to control: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4737529
Emax
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 4897.94 | ||
| 4868.90 | ||
| 5417.58 | ||
| 4066.82 | ||
| 4882.93 | ||
| 4194.01 | ||
| 3443.26 |